BBHC
KMTS

Brown Brothers Harriman & Co’s Kestra Medical Technologies KMTS Stock Holding History

Brown Brothers Harriman & Co’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79K Hold
3,104
– – ﹤0.01% 1032
2026
Q1 		$61.9K Hold
3,104
– – ﹤0.01% 1018
2025
Q4 		$82.3K Hold
3,104
– – ﹤0.01% 943
2025
Q3 		$73.8K Buy
3,104
+656
+27% +$11.7K ﹤0.01% 936
2025
Q2 		$40.6K Buy
2,448
+1,973
+415% +$43.1K ﹤0.01% 970
2025
Q1 		$11.8K Buy
+475
New +$10.9K ﹤0.01% 1042

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brown Brothers Harriman & Co's KMTS Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its Kestra Medical Technologies (KMTS) position steady in Q2 2026 at 3,104 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #1032.

Brown Brothers Harriman & Co first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $82.3K in Q4 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Brown Brothers Harriman & Co held 3,104 shares of Kestra Medical Technologies worth $79K as of Q2 2026.
  • Brown Brothers Harriman & Co left its Kestra Medical Technologies share count unchanged in Q2 2026.
  • Kestra Medical Technologies made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1032 holding.
  • Brown Brothers Harriman & Co first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • Brown Brothers Harriman & Co's Kestra Medical Technologies position peaked at $82.3K in Q4 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.